强心1号方抑制脓毒症小鼠过度促炎因子反应与小胶质细胞活化以改善认知与情绪功能障碍
该临床前研究在盲肠结扎穿刺诱导的脓毒症小鼠模型中,观察中药强心1号方(QX1)对行为学改变的影响及机制。口服QX1方显著改善生存率、认知障碍与情绪功能障碍,并抑制外周和中枢短期及长期过度促炎因子产生,伴随小胶质细胞活化减轻。机制涉及海马MAPK与NF-κB信号通路相关生物过程改变及小胶质细胞由M1向M2表型极化。
要点
- QX1方口服可改善脓毒症小鼠生存率及认知与情绪功能。
- QX1方抑制外周和中枢过度促炎因子产生并减轻小胶质细胞活化。
- 机制涉及海马MAPK、NF-κB通路及小胶质细胞M1/M2极化调节。
核心结论
- QX1方通过减轻神经炎症反应、抑制小胶质细胞活化并改变其极化方向,改善脓毒症小鼠认知缺陷与情绪功能障碍并提高生存率。
研究设计与样本
- 临床前研究,采用盲肠结扎穿刺诱导的脓毒症小鼠模型,口服给予QX1方,并以Morris水迷宫、新物体识别、高架十字迷宫和旷场实验评估行为学改变。
主要发现
- 口服QX1方显著改善脓毒症小鼠生存率,并减轻整体认知障碍与情绪功能障碍。
- QX1方显著抑制外周和中枢短期及长期过度促炎因子产生,并减轻小胶质细胞活化。
- QX1方改变海马突触传递、小胶质细胞活化、细胞因子产生、小胶质细胞极化及炎症反应等生物过程,涉及MAPK和NF-κB信号通路。
- QX1方下调M1表型小胶质细胞基因标志物Cd32、Socs3、Cd68,上调M2表型标志物Myc、Arg-1、Cd206。
临床怎么用
- 该临床前证据提示QX1方可能通过调控小胶质细胞极化与神经炎症改善脓毒症相关认知与情绪障碍,但尚需临床研究验证。
局限性
- 研究为动物实验,结论不能直接外推至脓毒症患者,临床有效性与安全性需进一步试验确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sepsis commonly leads to acute and long-term cognitive and affective impairments which are associated with increased mortality in patients. Neuroinflammation characterized by excessive cytokine release and immune cell activation underlies the behavioral changes associated with sepsis. We previously reported that the administration of a traditional Chinese herbal Qiang Xin 1 (QX1) formula improves survival in septic mice. This study was performed to better understand the effects and the mechanisms of QX1 formula treatment on behavioral changes in a preclinical septic model induced by cecal ligation and puncture. Oral administration of QX1 formula significantly improved survival, alleviated overall cognitive impairment and emotional dysfunction as assessed by the Morris water maze, novel object recognition testing, elevated plus maze and open field testing in septic mice. QX1 formula administration dramatically inhibited short and long-term excessive pro-inflammatory cytokine production both peripherally and centrally, and was accompanied by diminished microglial activation in septic mice. Biological processes including synaptic transmission, microglia cell activation, cytokine production, microglia cell polarization, as well as inflammatory responses related to signaling pathways including the MAPK signaling pathway and the NF-κB signaling pathway were altered prominently by QX1 formula treatment in the hippocampus of septic mice. In addition, QX1 formula administration decreased the expression of the M1 phenotype microglia gene markers such as Cd32, Socs3, and Cd68, while up-regulated M2 phenotype marker genes including Myc, Arg-1, and Cd206 as revealed by microarray analysis and Real-time PCR. In conclusion, QX1 formula administration attenuates cognitive deficits, emotional dysfunction, and reduces neuroinflammatory responses to improve survival in septic mice. Diminished microglial activation and altered microglial polarization are involved in the neuroprotective mechanism of QX1 formula.
引用
- Wang X, Xu X, Guo Y, et al. Qiang Xin 1 Formula Suppresses Excessive Pro-Inflammatory Cytokine Responses and Microglia Activation to Prevent Cognitive Impairment and Emotional Dysfunctions in Experimental Sepsis. Front Pharmacol. 2020. PMID: 32457609. doi:10.3389/fphar.2020.00579
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。